Xylitol and Heart Health: What the ESC 2026 Study Found

A study presented at the 2026 European Society of Cardiology Congress in Munich found that people with higher circulating xylitol levels had a greater risk of major adverse cardiovascular events than people with lower levels. The analysis covered 17,710 participants across two prospective cohorts, but because it was observational, it cannot establish that xylitol itself caused heart attacks, strokes, or deaths. 579

The headline findings

Researchers compared participants in the highest quarter of measured blood-xylitol concentrations with those in the lowest quarter. Major adverse cardiovascular events included death, myocardial infarction, or stroke. 5

• In the Canadian Longitudinal Study on Aging, the highest-xylitol group had a 57% higher adjusted risk of a major cardiovascular event than the lowest group over approximately six years. 58
• In the UK-based EPIC-Norfolk cohort, the corresponding difference was an 18% higher risk over 30 years. 58
• Event rates generally increased across the xylitol quartiles, suggesting a dose-response pattern rather than a difference limited to the two extreme groups. 78
• The association remained after researchers accounted for established cardiovascular risk factors, including body-mass index, hypertension, diabetes, and lipid levels. 67

These are relative risk comparisons between groups with different measured blood levels. They do not mean that 57% of people who use xylitol will have a heart attack or stroke, and the findings do not establish the absolute risk for any individual.

Who was studied?

The analysis combined data from two prospective observational cohorts, totaling 17,710 participants. One was a Canadian cohort followed for about six years; the other was EPIC-Norfolk, which provided follow-up extending to 30 years. 58

The researchers analyzed blood xylitol concentrations and then compared subsequent cardiovascular outcomes. This design can identify a relationship between an exposure marker and later health events, but it does not randomly assign people to consume xylitol. As a result, differences between participants—or changes in health that affected both xylitol levels and cardiovascular risk—could partly explain the results.

Why xylitol is relevant to everyday products

Xylitol is a sugar alcohol used in a range of sugar-free and low-calorie products, including chewing gum, mints, toothpaste, jams, yogurts, ice cream, beverages, and some oral-care or pharmaceutical products. 347

Small amounts occur naturally in some foods, while added xylitol can expose people to substantially higher amounts. The contrast matters because the study’s question concerns circulating blood levels and the possible implications of sustained or high exposure—not simply whether a product contains a small amount of xylitol. 7

A possible clotting mechanism

Earlier work by the investigators suggested that xylitol may increase platelet activity and promote clot formation. That provides a biologically plausible pathway through which higher circulating levels could potentially relate to thrombotic events such as heart attack or stroke. 716

However, a plausible mechanism is not proof of causation. It makes the association important to investigate, but it does not demonstrate that xylitol exposure produced the outcomes in this observational analysis.

What the study does not prove

The study was not a randomized clinical trial of xylitol consumption. Its results therefore remain vulnerable to residual confounding and reverse causation, even though the analysis adjusted for several major cardiovascular risk factors. 57

It also does not establish:

• the exact amount or duration of xylitol exposure that might matter;
• whether blood xylitol levels accurately represent a person’s long-term intake from food, gum, medicines, or oral-care products;
• which groups, if any, are most susceptible; or
• whether lowering xylitol exposure would reduce cardiovascular events.

The most defensible interpretation is that higher circulating xylitol was associated with higher cardiovascular risk in two cohorts, with a stronger short-term association in the Canadian analysis and a smaller long-term association in EPIC-Norfolk. The difference between those estimates is another reason not to treat either figure as a universal personal-risk calculation.

What people should take from the findings

The results are a reason to question the assumption that sugar substitutes are automatically risk-free at high or sustained exposures—not a reason to replace xylitol with more added sugar. Added sugar has its own established health concerns, and the study does not compare xylitol directly with sugar. 7

Further research should clarify dose, exposure sources, biological mechanisms, susceptible populations, and long-term cardiovascular safety. Larger studies, mechanistic research, and ideally randomized evidence would be needed before changing clinical or public-health guidance about xylitol. 1479